참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Calcium Carbonate | HCID 10112 | — |
| 반응물 | Ammonium Chloride | HCID 25517 | — |
| 반응물 | (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | HCID 107526 | — |
| 반응물 | Biotin | HCID 171548 | — |
| 반응물 | Monobasic potassium phosphate | HCID 516951 | — |
| 반응물 | Thiaminhydrochloride | HCID 67590811 | — |
| 생성물 | L-Lysine | HCID 5962 | — |
반응 단계
A culture medium containing 36 mg/ml glucose, 20 mg/ml ammonium chloride, 1 mg/ml KH2PO4, 0.4 mg/ml MgSO4.7H2O, 10 μg/ml FeSO4.7H2O, 8 μg/ml MnSO4.7H2O, 1 μg/ml (as N) of acid hydrolyzate of soybean protein, 0.1 μg/ml thiamin hydrochloride and 0.3 μg/ml biotin was prepared. Thirty milliliters of this medium was dispensed in 500-ml shake flasks, sterilized by heating at 115° C. for ten minutes, and 1 g each of calcium carbonate, previously sterilized by dry heating, was further added. Each strain listed in Table 2 was innoculated to this medium, and fermentation was continued at 31.5° C. for 48 hours on a reciprocating shaker. Table 3 shows the amount of L-lysine accumulated in each fermentation liquor. As is apparent from the table, all of the drug-resistant strains tested produced L-lysine in good yields.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05179010 |
|---|
| 출처 데이터셋 | uspto-grants-1993_01 |
|---|
| ORD ID | ord-6e6476b6b05f48ef9b82dbbbefef5549 |
|---|
| 출처 메모 | uspto-grants-1993_01 |
|---|